Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation-Reference-Cited by-同舟云学术

Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation

Published:2016-09-09 Issue:12 Volume:15 Page:3040-3054
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Yamaoka Toshimitsu,Ohmori Tohru,Ohba Motoi,Arata Satoru,Kishino Yasunari,Murata Yasunori,Kusumoto Sojiro,Ishida Hiroo,Shirai Takao,Hirose Takashi,Ohnishi Tsukasa,Sasaki Yasutsuna

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review;Critical Reviews in Oncology/Hematology;2024-02

2. Molecular features and clinical outcomes of EGFR-mutated, MET-amplified non-small-cell lung cancer after resistance to dual-targeted therapy;Therapeutic Advances in Medical Oncology;2024-01

3. The Relationship between IGF Pathway and Acquired Resistance to Tyrosine Kinase Inhibitors in Cancer Therapy;Frontiers in Bioscience-Landmark;2023-08-11

4. The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer;International Immunopharmacology;2023-01

5. EGFR TKI resistance in lung cancer cells using RNA sequencing and analytical bioinformatics tools;Journal of Biomolecular Structure and Dynamics;2022-12-16